This 4K 3d animation of drug development & manufacture, shows the all the stages from cell line development to clinical production. Watch the video to learn more about the journey a molecule takes to get to the market.
Affimers are small single domain proteins, engineered to be an alternative to antibodies. Antibodies are well established reagents, but have many performance limitations. They also generally require the use of animals for production, so the range available is limited by the immune system.
Affimers are a revolutionary new, engineered alternative to antibodies. They can be generated in a fraction of the time, are highly specific and aren’t limited by the immune system. They can be manufactured easily, with consistent quality and without the need for animals. Critically, Affimers require no change your workflow – they simply replace antibodies.